Lanxess AG

PINK:LNXSF USA Specialty Chemicals
Market Cap
$2.33 Billion
Market Cap Rank
#5357 Global
#3175 in USA
Share Price
$27.00
Change (1 day)
+0.00%
52-Week Range
$27.00 - $31.44
All Time High
$79.84
About

LANXESS Aktiengesellschaft, a specialty chemicals company, engages in the development, manufacture, and marketing of chemical intermediates, additives, and consumer protection products worldwide. It operates through three segments: Consumer Protection, Specialty Additives, and Advanced Intermediates. The company provides material protection products; disinfectant, hygiene, and preservative soluti… Read more

Lanxess AG (LNXSF) - Net Assets

Latest net assets as of September 2025: $3.91 Billion USD

Based on the latest financial reports, Lanxess AG (LNXSF) has net assets worth $3.91 Billion USD as of September 2025.

Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($8.18 Billion) and total liabilities ($4.28 Billion). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.

Key Net Assets Metrics

Metric Value
Current Net Assets $3.91 Billion
% of Total Assets 47.76%
Annual Growth Rate 5.82%
5-Year Change 53.12%
10-Year Change 97.68%
Growth Volatility 17.04

Lanxess AG - Net Assets Trend (2003–2024)

This chart illustrates how Lanxess AG's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.

Annual Net Assets for Lanxess AG (2003–2024)

The table below shows the annual net assets of Lanxess AG from 2003 to 2024.

Year Net Assets Change
2024-12-31 $4.59 Billion +1.89%
2023-12-31 $4.51 Billion +1.81%
2022-12-31 $4.43 Billion +17.68%
2021-12-31 $3.76 Billion +25.44%
2020-12-31 $3.00 Billion +13.30%
2019-12-31 $2.65 Billion -4.54%
2018-12-31 $2.77 Billion -18.75%
2017-12-31 $3.41 Billion -8.45%
2016-12-31 $3.73 Billion +60.48%
2015-12-31 $2.32 Billion +7.50%
2014-12-31 $2.16 Billion +13.74%
2013-12-31 $1.90 Billion -18.49%
2012-12-31 $2.33 Billion +12.39%
2011-12-31 $2.07 Billion +17.77%
2010-12-31 $1.76 Billion +21.87%
2009-12-31 $1.45 Billion +2.70%
2008-12-31 $1.41 Billion -7.74%
2007-12-31 $1.52 Billion +6.79%
2006-12-31 $1.43 Billion +13.69%
2005-12-31 $1.26 Billion -7.99%
2004-12-31 $1.36 Billion -2.57%
2003-12-31 $1.40 Billion --

Equity Component Analysis

This analysis shows how different components contribute to Lanxess AG's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.

Equity Composition Insights

  • Retained earnings have grown by 82000000000.0% over the analyzed period, indicating profitable operations and earnings retention.

Current Equity Component Breakdown (December 2024)

Component Amount Percentage
Common Stock $86.00 Million 1.88%
Other Comprehensive Income $4.68 Billion 101.98%
Total Equity $4.59 Billion 100.00%

Lanxess AG Competitors by Market Cap

The table below lists competitors of Lanxess AG ranked by their market capitalization.

Equity Growth Attribution

This analysis shows how different factors contributed to changes in Lanxess AG's equity between the two most recent reporting periods.

Equity Growth Insights

  • From 2023 to 2024, total equity changed from 4,501,000,000 to 4,586,000,000, a change of 85,000,000 (1.9%).
  • Net loss of 177,000,000 reduced equity.
  • Dividend payments of 9,000,000 reduced retained earnings.
  • Other comprehensive income increased equity by 705,000,000.
  • Other factors decreased equity by 434,000,000.

Equity Change Factors (2023 to 2024)

Factor Impact Contribution
Net Income $-177.00 Million -3.86%
Dividends Paid $9.00 Million -0.2%
Other Comprehensive Income $705.00 Million +15.37%
Other Changes $-434.00 Million -9.46%
Total Change $- 1.89%

Book Value vs Market Value Analysis

This analysis compares Lanxess AG's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.

Valuation Insights

  • Current price-to-book ratio: 0.51x
  • The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
  • The price-to-book ratio has decreased from 1.70x to 0.51x over the analyzed period, indicating reduced market premium.

Historical Price-to-Book Ratios

Date Book Value per Share Market Price P/B Ratio
2003-12-31 $15.91 $27.00 x
2004-12-31 $15.73 $27.00 x
2005-12-31 $14.64 $27.00 x
2006-12-31 $16.58 $27.00 x
2007-12-31 $17.91 $27.00 x
2008-12-31 $16.72 $27.00 x
2009-12-31 $17.21 $27.00 x
2010-12-31 $20.99 $27.00 x
2011-12-31 $24.73 $27.00 x
2012-12-31 $27.82 $27.00 x
2013-12-31 $22.78 $27.00 x
2014-12-31 $24.40 $27.00 x
2015-12-31 $25.24 $27.00 x
2016-12-31 $27.88 $27.00 x
2017-12-31 $24.99 $27.00 x
2018-12-31 $30.37 $27.00 x
2019-12-31 $30.21 $27.00 x
2020-12-31 $34.66 $27.00 x
2021-12-31 $43.50 $27.00 x
2022-12-31 $51.20 $27.00 x
2023-12-31 $52.13 $27.00 x
2024-12-31 $53.11 $27.00 x

Capital Efficiency Dashboard

This dashboard shows how efficiently Lanxess AG utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.

Capital Efficiency Insights

  • Current Return on Equity (ROE): -3.86%
  • The company may be facing challenges in efficiently utilizing shareholder equity.
  • DuPont Analysis Breakdown:
  • • Net Profit Margin: -2.78%
  • • Asset Turnover: 0.66x
  • • Equity Multiplier: 2.12x
  • Recent ROE (-3.86%) is below the historical average (5.05%), suggesting potential challenges in capital efficiency.

Historical Capital Efficiency Metrics

Year Return on Equity Net Profit Margin Asset Turnover Equity Multiplier Economic Value Added
2003 -73.34% -15.77% 1.39x 3.34x $-1.13 Billion
2004 -0.53% -0.10% 1.48x 3.44x $-140.10 Million
2005 -4.36% -0.76% 1.65x 3.50x $-177.90 Million
2006 14.04% 2.84% 1.65x 3.00x $56.70 Million
2007 7.43% 1.69% 1.63x 2.69x $-38.80 Million
2008 13.16% 2.78% 1.41x 3.34x $43.90 Million
2009 2.79% 0.79% 1.00x 3.54x $-103.20 Million
2010 21.71% 5.32% 1.26x 3.25x $204.40 Million
2011 24.59% 5.77% 1.28x 3.34x $300.20 Million
2012 21.94% 5.59% 1.21x 3.25x $276.50 Million
2013 -8.39% -1.92% 1.22x 3.59x $-348.50 Million
2014 2.18% 0.59% 1.10x 3.36x $-168.90 Million
2015 7.14% 2.09% 1.09x 3.13x $-66.00 Million
2016 7.52% 2.49% 0.78x 3.87x $-63.20 Million
2017 3.80% 0.90% 0.93x 4.55x $-141.70 Million
2018 15.50% 5.99% 0.83x 3.12x $153.00 Million
2019 7.68% 3.01% 0.78x 3.26x $-61.90 Million
2020 29.49% 14.50% 0.69x 2.96x $584.90 Million
2021 7.11% 3.53% 0.72x 2.80x $-108.60 Million
2022 5.65% 3.09% 0.72x 2.55x $-192.10 Million
2023 9.84% 6.60% 0.69x 2.15x $-7.10 Million
2024 -3.86% -2.78% 0.66x 2.12x $-635.60 Million

Industry Comparison

This section compares Lanxess AG's net assets metrics with peer companies in the Specialty Chemicals industry.

Industry Context

  • Industry: Specialty Chemicals
  • Average net assets among peers: $7,181,833,981
  • Average return on equity (ROE) among peers: 7.11%

Peer Company Comparison

Company Net Assets Return on Equity Debt-to-Equity Market Cap
Lanxess AG (LNXSF) $3.91 Billion -73.34% 1.09x $1.74 Billion
AirBoss of America Corp (ABSSF) $197.00 Million -16.19% 1.24x $57.06 Million
Asia Carbon Industries Inc (ACRB) $19.13 Million 17.11% 0.33x $0.98
Aimia Inc (AIMFF) $1.29 Billion -4.63% 2.83x $103.68 Million
L'Air Liquide S.A (AIQUF) $11.83 Billion 14.08% 1.26x $107.70 Billion
Akzo Nobel N.V (AKZOF) $7.58 Billion 14.03% 1.29x $9.73 Billion
Albemarle Corp (ALB) $545.00 Million 9.41% 1.09x $19.53 Billion
ALPEK S.A.B. de C.V (ALPKF) $49.59 Billion 15.64% 1.50x $214.40 Million
Altech Batteries Limited (ALTHF) $97.54 Million -5.87% 0.01x $27.89 Million
Arcadium Lithium plc (ALTM) $333.00 Million 14.14% 0.12x $6.26 Billion
Alto Ingredients Inc (ALTO) $345.21 Million 13.35% 0.40x $212.84 Million